Pontifical Catholic University of Chile

Penetron Expands Sales & Technical Support Team to Maintain Growth Momentum in the Western USA

Retrieved on: 
Tuesday, January 10, 2023

EAST SETAUKET, N.Y., Jan. 10, 2023 /PRNewswire-PRWeb/ -- On January 3, 2023, Penetron announced the appointment of Lawson Sanford as Account Manager for the West Coast market, where Penetron continues to grow its market share. This new appointment will further strengthen the Penetron Technical and Customer Support team in California, Nevada, and Arizona.

Key Points: 
  • This new appointment will further strengthen the Penetron Technical and Customer Support team in California, Nevada, and Arizona.
  • This new appointment will further strengthen the Penetron Technical and Customer Support team in California, Nevada, and Arizona.
  • Based in San Diego, California, Lawson Sanford is responsible for Penetron customers across Southern California, Southern Nevada, and the state of Arizona.
  • For more information on Penetron waterproofing solutions, please visit penetron(dot)com or Facebook(dot)com/ThePenetronGroup, email CRDept(at)penetron(dot)com or contact the Corporate Relations Department at 631-941-9700.

JAPAN HOUSE Los Angeles Presents “Designing With Disaster: Stories From Seven Regenerative Cities”

Retrieved on: 
Thursday, January 5, 2023

LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles , a Japanese cultural destination in the heart of Hollywood, announces its upcoming exhibition “Designing with Disaster: Stories from Seven Regenerative Cities” on display from January 27 – April 2, 2023.

Key Points: 
  • LOS ANGELES, Jan. 05, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles , a Japanese cultural destination in the heart of Hollywood, announces its upcoming exhibition “Designing with Disaster: Stories from Seven Regenerative Cities” on display from January 27 – April 2, 2023.
  • The exhibition also features illuminated Regenerative City Wells (“Wells”) with an immersive physical, video, and audio experience envisioning seven hypothetical regenerative cities.
  • In conjunction with the upcoming exhibition, the UCLA Terasaki Center for Japanese Studies and JAPAN HOUSE Los Angeles will co-host the Global Japan Forum 2023: Designing with Disaster to be held on January 28, 2023 from 2 p.m. – 5 p.m. at JAPAN HOUSE Los Angeles.
  • Walk-ins are invited and the gallery is open daily from
    For more information, visit the JAPAN HOUSE Los Angeles website and social channels: Facebook , Instagram , Twitter , YouTube and LinkedIn .

Pan American Energy Announces Addition to Advisory Team and Related Option Issuance

Retrieved on: 
Friday, December 2, 2022

CALGARY, Alberta, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (the Company or Pan American) (CSE: PNRG) (OTC PINK: PAANF) (FRA: SS6) is pleased to announce that Emilio Bunel has joined the Companys advisory team effective December 1st, 2022.

Key Points: 
  • CALGARY, Alberta, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Pan American Energy Corp. (the Company or Pan American) (CSE: PNRG) (OTC PINK: PAANF) (FRA: SS6) is pleased to announce that Emilio Bunel has joined the Companys advisory team effective December 1st, 2022.
  • Jason Latkowcer, CEO and Director comments, We are excited to have someone with Emilios professional experience join our technical advisory team.
  • Pan American also announces that it has granted 50,000 stock options (Options), each with an exercise price of $0.80, to Mr. Bunel in connection with his appointment to the technical advisory team.
  • About Pan American Energy Corp.
    Pan American Energy Corp. (CSE: PNRG) (OTC PINK: PAANF) (FSE: SS6) is an exploration stage company engaged principally in the acquisition, exploration and development of mineral properties containing battery metals in North America.

NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer

Retrieved on: 
Tuesday, May 10, 2022

Dr. Quiroz brings twenty years of drug development experience in academia and the pharmaceutical and biotechnology industries.

Key Points: 
  • Dr. Quiroz brings twenty years of drug development experience in academia and the pharmaceutical and biotechnology industries.
  • Dr Jorge A. Quiroz, newly appointed Chief Medical Officer at NMD Pharma, said: It is a great time to be joining NMD Pharma as it concludes its Phase IIa study of NMD670 in myasthenia gravis patients and progresses parallel programs based on the novel and exciting science of ClC-1 inhibition.
  • Thomas Holm Pedersen, Chief Executive Officer of NMD Pharma, said: Jorge brings years of experience leading clinical teams and programs, and I am pleased that he is joining NMD Pharma at such a pivotal time.
  • In his new role, Dr Quiroz will be based near Boston, Massachusetts where NMD Pharma has recently expanded its presence.

Mantra Bio Announces Appointment of Maria Fuentes, Ph.D. as Chief Scientific Officer

Retrieved on: 
Tuesday, September 21, 2021

SAN FRANCISCO, Sept. 21, 2021 /PRNewswire/ -- Mantra Bio today announced the appointment of Maria Fuentes, Ph.D. as the company's Chief Scientific Officer.

Key Points: 
  • SAN FRANCISCO, Sept. 21, 2021 /PRNewswire/ -- Mantra Bio today announced the appointment of Maria Fuentes, Ph.D. as the company's Chief Scientific Officer.
  • Dr. Fuentes joins Mantra Bio after holding research leadership positions at Roche, Bristol-Myers Squibb, and most recently Blade Therapeutics, where she was Executive Vice President of Research.
  • "Maria's appointment reflects the significant progress Mantra Bio has made in refining and validating our REVEAL Targeted Exosome Delivery platform and drug discovery efforts.
  • Mantra Bio is developing novel next generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs).